GRCE
Grace Therapeutics, Inc. · Healthcare
Opaleye Management Inc. bought $136K of Grace Therapeutics, Inc.
10% owner
Bought$136,178
$1.92Price
71,065Shares
+2%Stake
What GRCE did for a copier
- $1,000 copied at Mon, Oct 19 open, $1.89
- $1,021
- S&P 500, same days
- −0.9%
4 of 30 trading days so far, to the Oct 23 close.
Opaleye Management Inc.'s record
63 other buys with 3 months of prices since 2016: on average +20.3% against the S&P 500, and 33 of 63 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Oct 14. Filed Fri, Oct 16, 8:42 PM ET, after the close. Returns use the Oct 19 open and the Oct 23 close. Not investment advice.